CareMax (CMAX)
(Delayed Data from NSDQ)
$1.76 USD
-0.05 (-2.76%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $1.76 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.76 USD
-0.05 (-2.76%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $1.76 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Zacks News
CareMax, Inc. (CMAX) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
CareMax (CMAX) delivered earnings and revenue surprises of -39.55% and 14.94%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Outbrain Inc. (OB) Reports Break-Even Earnings for Q2
by Zacks Equity Research
Outbrain (OB) delivered earnings and revenue surprises of 100% and 1.19%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Duolingo (DUOL) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Duolingo (DUOL) is likely to witness a year-over-year increase in revenues for the first quarter of 2024.
Marathon Digital (MARA) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Marathon Digital's (MARA) first-quarter 2024 earnings and revenues are expected to increase year over year.
Will Top-Line Improvement Aid Arm Holdings' (ARM) Q1 Earnings?
by Zacks Equity Research
We expect Arm Holdings (ARM) to witness strong growth across businesses in the fourth quarter of fiscal 2024.
Arq (ARQ) Set to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Arq (ARQ) is expected to record top and bottom-line growth when it reports first-quarter 2024 results.
Jacobs (J) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Digital & technological solutions and growth in infrastructural efforts are likely to have reflected in Jacobs' (J) fiscal second-quarter performance. However, higher expenses might have been a headwind.
New Strong Sell Stocks for April 1st
by Zacks Equity Research
BMRC, CPRI and CMAX have been added to the Zacks Rank #5 (Strong Sell) List on April 1, 2023.
New Strong Sell Stocks for March 28th
by Zacks Equity Research
ASLE, CPRI and CMAX have been added to the Zacks Rank #5 (Strong Sell) List on March 28, 2023.
New Strong Sell Stocks for March 20th
by Zacks Equity Research
CMAX, LNZA and HSON have been added to the Zacks Rank #5 (Strong Sell) List on March 20, 2024.
ZipRecruiter, Inc. (ZIP) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
ZipRecruiter, Inc. (ZIP) delivered earnings and revenue surprises of 130% and 4.47%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
CareMax, Inc. (CMAX) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
CareMax, Inc. (CMAX) delivered earnings and revenue surprises of -150% and 18.83%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Bitfarms Ltd. (BITF) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Bitfarms Ltd. (BITF) delivered earnings and revenue surprises of -40% and 4.20%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
MeridianLink (MLNK) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
MeridianLink (MLNK) delivered earnings and revenue surprises of -50% and 2.38%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
CareMax, Inc. (CMAX) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
CareMax, Inc. (CMAX) delivered earnings and revenue surprises of -20% and 6.74%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Ecovyst (ECVT) Meets Q1 Earnings Estimates
by Zacks Equity Research
Ecovyst (ECVT) delivered earnings and revenue surprises of 0% and 3.45%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
CareMax, Inc. (CMAX) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
CareMax, Inc. (CMAX) delivered earnings and revenue surprises of -433.33% and 7.16%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
CareMax, Inc. (CMAX) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
by Zacks Equity Research
CareMax, Inc. (CMAX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sterling Check Corp. (STER) Lags Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Sterling Check Corp. (STER) delivered earnings and revenue surprises of -19.23% and 4.79%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for February 1st
by Zacks Equity Research
BWAY, CMAX and EQBK have been added to the Zacks Rank #5 (Strong Sell) List on February 1, 2023.
New Strong Sell Stocks for January 30th
by Zacks Equity Research
BFC, CMAX and BWAY have been added to the Zacks Rank #5 (Strong Sell) List on January 30, 2023.
CareMax, Inc. (CMAX) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
CareMax, Inc. (CMAX) delivered earnings and revenue surprises of -127.27% and 11.47%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Aptiv PLC (APTV) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Aptiv PLC (APTV) delivered earnings and revenue surprises of 23.08% and 7.71%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Implied Volatility Surging for CareMax (CMAX) Stock Options
by Zacks Equity Research
Investors need to pay close attention to CorMedix (CMAX) stock based on the movements in the options market lately.
CareMax (CMAX) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
CareMax (CMAX) has been struggling lately, but the selling pressure may be coming to an end soon.